Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 128Gynecologic 5Other 3Thoracic 2Genitourinary 2Tumor-Agnostic 1Other neoplasm 1Gastrointestinal 1Endocrine 1

Conditions

Breast Neoplasms 3Obesity 2Sexual Dysfunctions, Psychological 1Arthralgia 1

Interventions

Exercise 27Metformin 20Surveys and Questionnaires 19Methods 14Educational Status 12Early Intervention, Educational 11Counseling 11Tirzepatide 9Standard of Care 9Nutrition Assessment 9Diet Therapy 9Resistance Training 8Radiotherapy 8Diet 8Interviews as Topic 7Liraglutide 6semaglutide 5Radiation 5Low-Level Light Therapy 5Exenatide 5Diet, Mediterranean 5Dexamethasone 5Cryotherapy 5Caloric Restriction 5Blood Specimen Collection 5Bariatric Surgery 5Vitamin D 4Therapeutics 4Sugars 4Specimen Handling 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × exemestane × Other × Clear all
NCT07596212 2026-05-19

BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder

University of Illinois at Chicago

Phase 1/2 Not yet recruiting
100 enrolled
BreastOther

Breast Neoplasms, Sexual Dysfunctions, Psychological

NCT01896050 2016-06-28

LOGRIBMET

University of Michigan Rogel Cancer Center

Completed
115 enrolled 14 charts
BreastOther

Breast Neoplasms, Obesity, Arthralgia

NCT00933309 2016-02-19

The Impact of Obesity and Obesity Treatments on Breast Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
25 enrolled
BreastOther

Breast Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡